Medical News

RSS

Omicron RBD-ACE2 binding found to be stronger than wild type SARS-CoV-2 strain

Researchers recently investigated the effect of SARS-CoV-2 Omicron variant mutations on the binding of the receptor-binding domain and angiotensin-converting enzyme-2 to study the overall binding profile of the RBD-ACE2 system.

16 Feb 2022

CRISPR-Cas12a assay to diagnose SARS-CoV-2 infection and detect strain-specific SNPs for variant identification

The multiplex detection approach outlined in this study has the potential to address the need to rapidly characterize the phenotype and clinical response to continually emerging SARS-CoV-2 variants as the COVID-19 pandemic continues.

16 Feb 2022

COVID-19 vaccine boosters shown to confer protection against the SARS-CoV-2 Omicron variant

In a new study, researchers investigated whether a COVID-19 vaccine booster dose is effective against the SARS-CoV-2 Omicron variant.

16 Feb 2022

Features of platelet-immune crosstalk in healthy recipients of two doses of mRNA-based SARS-CoV-2 vaccine BNT162b2

Researchers investigated the role of platelets in the adverse immune response against a COVID-19 vaccine.

16 Feb 2022

COVID-Somnia: the relationship between COVID-19 and insomnia

Researchers explored the links between COVID-19 and sleep disorders such as insomnia using a thorough literature review.

16 Feb 2022

The emergence of infectious diseases from the "germ’s eye view”

The study highlighted that the disruption caused by the COVID-19 pandemic has shown that human societies remain ill-prepared and susceptible to novel infectious diseases.

16 Feb 2022

Study shows mRNA COVID-19 vaccination in pregnancy can prevent hospitalization among infants

A report published in the CDC’s Morbidity and Mortality Weekly Report (MMWR) shows how primary two-dose vaccination series against coronavirus disease 2019 (COVID-19) during pregnancy is linked to a reduced risk of COVID-19–associated hospitalization among infants six months of age or younger.

16 Feb 2022

Superior immune response in vaccinated after infection with Omicron compared to unvaccinated

In a recent study posted to the medRxiv* preprint server, researchers evaluated the cross-reactivity of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Omicron variant-triggered neutralization and fragment crystallizable (Fc) effector functions between coronavirus disease 2019 (COVID-19)-vaccinated and unvaccinated individuals in South Africa.

16 Feb 2022

Researchers to test personalized physical activity programs for stroke survivors

A Melbourne researcher has been awarded a $69,980 Stroke Foundation Seed Grant to investigate what level of physical activity is needed in stroke recovery to have a positive effect on health.

16 Feb 2022

Study to determine the best ways for supporting stroke patients' families

A new study has been designed to determine the best ways to support an entire family unit after a parent has a stroke.

15 Feb 2022

New project aims to improve the lives of stroke survivors with aphasia

A Queensland researcher will lead a new project aimed at improving the lives of people with aphasia, a debilitating condition that impacts one in three survivors of stroke.

15 Feb 2022

New research aims to reduce dysphagia after stroke

New research, aimed at reducing the debilitating impact of the condition dysphagia after stroke, is among the recipients of the Stroke Foundation 2022 Research Grants program.

15 Feb 2022

Mechanism of SARS-CoV-2 Nsp1 interaction with ribosomal complexes

In a recent study posted to the bioRxiv* preprint server, the team of researchers explored the protein-protein interaction between the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) non-structural protein 1 (Nsp1) and host 40S and 43S ribosomal subunits.

15 Feb 2022

The long-term consequences of SARS-CoV-2 infection in people with HIV

In a recent study posted to the medRxiv* preprint server, an interdisciplinary team of researchers from the United States (US) analyzed a cohort of patients with human immunodeficiency virus (HIV) (PWH) recovering from coronavirus disease 2019 (COVID-19) and characterized severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-specific immune responses in these patients.

15 Feb 2022

Study suggests folic acid supplementation linked to increased risk for COVID-19 diagnosis

In a recent study posted to the medRxiv* preprint server, researchers evaluated if folic acid or methotrexate use impacts the risk of coronavirus disease 2019 (COVID-19) diagnosis or associated mortality in the United Kingdom (UK).

15 Feb 2022

Use of immunosuppressants for inflammatory rheumatic diseases and the associated risk of severe COVID-19

A recent study posted to the medRxiv* preprint server investigated the risk of severe/fatal coronavirus disease 2019 (COVID-19) in patients treated with immunosuppressants for inflammatory rheumatic diseases (IRD).

15 Feb 2022

Biomarker could predict pathologic response to chemotherapy among bladder cancer patients

Long-term survival data from the first prospective, randomized biomarker validation trial in patients with muscle-invasive bladder cancer being treated with cisplatin-based chemotherapy before surgery will be reported at the 2022 Genitourinary Cancers Symposium of the American Society of Clinical Oncology (GU ASCO) on February 18, 2022.

15 Feb 2022

Government asks experts to inform the refresh of UK's Biological Security Strategy

The Government is today (Wednesday 16 February) asking for health and security experts to inform the refresh of the UK's Biological Security Strategy, which aims to protect the country from a range of biological threats, including emerging infectious diseases and potential misuse by hostile actors.

15 Feb 2022

Transformational $104 million gift will help VCU to expand treatment options for liver diseases

Virginia Commonwealth University will radically expand treatment options for liver and liver-related metabolic diseases thanks to a historic, transformational $104 million gift from Richard Todd Stravitz, M.D., and his family's Barbara Brunckhorst Foundation.

15 Feb 2022

Pandemic has led to delay in diagnosis of breast cancer

The COVID-19 pandemic upended many aspects of daily life, particularly in the first months and year. Not least among the changes: decreased use of ordinary health care, such as routine medical exams and screenings.

15 Feb 2022

Medical News

Omicron RBD-ACE2 binding found to be stronger than wild type SARS-CoV-2 strain

CRISPR-Cas12a assay to diagnose SARS-CoV-2 infection and detect strain-specific SNPs for variant identification

COVID-19 vaccine boosters shown to confer protection against the SARS-CoV-2 Omicron variant

Features of platelet-immune crosstalk in healthy recipients of two doses of mRNA-based SARS-CoV-2 vaccine BNT162b2

COVID-Somnia: the relationship between COVID-19 and insomnia

The emergence of infectious diseases from the "germ’s eye view”

Study shows mRNA COVID-19 vaccination in pregnancy can prevent hospitalization among infants

Superior immune response in vaccinated after infection with Omicron compared to unvaccinated

Researchers to test personalized physical activity programs for stroke survivors

Study to determine the best ways for supporting stroke patients' families

New project aims to improve the lives of stroke survivors with aphasia

New research aims to reduce dysphagia after stroke

Mechanism of SARS-CoV-2 Nsp1 interaction with ribosomal complexes

The long-term consequences of SARS-CoV-2 infection in people with HIV

Study suggests folic acid supplementation linked to increased risk for COVID-19 diagnosis

Use of immunosuppressants for inflammatory rheumatic diseases and the associated risk of severe COVID-19

Biomarker could predict pathologic response to chemotherapy among bladder cancer patients

Government asks experts to inform the refresh of UK's Biological Security Strategy

Transformational $104 million gift will help VCU to expand treatment options for liver diseases

Pandemic has led to delay in diagnosis of breast cancer

How Programmable Nanobiology Could Drive the Fifth Industrial Revolution

Dr. Anthony Grice

Building quality into drug development for safer, faster medicines

Latest News